Ecopetrol SA(EC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EC Ecopetrol SA

Trading 04-16 15:08:55 EDT

13.66

+0.49

+3.68%

High13.77	Low13.17	Vol2.25M
Open13.18	D1 Closing13.17	Amplitude4.52%
Mkt Cap28.07B	Tradable Cap3.19B	Total Shares2.06B
T/O30.26M	T/O Rate0.97%	Tradable Shares233.42M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EC","market":"US","secType":"STK","nameCN":"Ecopetrol SA","latestPrice":13.655,"timestamp":1776366524280,"preClose":13.17,"halted":0,"volume":2252649,"delay":0,"changeRate":0.036826119969627896,"floatShares":233420503,"shares":2055834734,"eps":1.164741,"marketStatus":"Trading","change":0.485,"latestTime":"04-16 15:08:55 EDT","open":13.18,"high":13.765,"low":13.17,"amount":30260951.330904,"amplitude":0.045178,"askPrice":13.66,"askSize":400,"bidPrice":13.65,"bidSize":929,"shortable":3,"etf":0,"ttmEps":1.164741,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1776369600000},"marketStatusCode":2,"adr":1,"adrRate":20,"listingDate":1221710400000,"exchange":"NYSE","adjPreClose":13.17,"dividendRate":0.072574,"preHourTrading":{"tag":"盘前","latestPrice":13.32,"preClose":13.17,"latestTime":"09:28 EDT","volume":1140,"amount":15180.9012,"timestamp":1776346130876,"change":0.15,"changeRate":0.01139,"amplitude":0.048049},"postHourTrading":{"tag":"盘后","latestPrice":13.1169,"preClose":13.17,"latestTime":"19:47 EDT","volume":5989,"amount":78828.7182,"timestamp":1776296844090,"change":-0.0531,"changeRate":-0.004032,"amplitude":0.004791},"volumeRatio":0.991559,"impliedVol":0.5555,"impliedVolPercentile":0.608},"requestUrl":"/m/hq/s/EC","defaultTab":"news","newsList":[{"id":"2627433481","title":"Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627433481","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627433481?lang=en_us&edition=fundamental","pubTime":"2026-04-13 13:00","pubTimestamp":1776056400,"startTime":"0","endTime":"0","summary":"Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/13/3272191/0/en/Dupixent-dupilumab-Approved-in-the-EU-as-the-First-Targeted-Medicine-to-Treat-Young-Children-with-Chronic-Spontaneous-Urticaria-CSU.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BP","LU0882574055.USD","LU2023250504.SGD","BK4007","LU2089984988.USD","EC","LU1974910355.USD","LU0114720955.EUR","LU0109394709.USD","VHT","LU0320765992.SGD","BK4139","BK4096","BK4585","LU0053666078.USD","BK4201","LU1829250122.USD","LU0058720904.USD","LU0320765646.SGD","SNY","LU0072461881.USD","LU2468319806.SGD","LU0289739699.SGD","BPH","LU0823434740.USD","LU2362541273.HKD","BK4156","LU2237438978.USD","LU2362541513.USD","IXJ","REGN","LU0823416689.USD","LU2106854487.HKD","PN","BK4550","LU1917777945.USD","LU0889565916.HKD","BK4588","LU1162221912.USD","LU0162691827.USD","LU2362540622.SGD","IE00BFXG1179.USD","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626718729","title":"Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626718729","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626718729?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:00","pubTimestamp":1775736000,"startTime":"0","endTime":"0","summary":"BOSTON, April  09, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3270878/0/en/Rhythm-Pharmaceuticals-to-Report-First-Quarter-2026-Financial-Results-on-Tuesday-May-5-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","VUS","AVP","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625955756","title":"Ecopetrol Board Approves President's Unpaid Leave of Absence","url":"https://stock-news.laohu8.com/highlight/detail?id=2625955756","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625955756?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:37","pubTimestamp":1775569029,"startTime":"0","endTime":"0","summary":"Ecopetrol  said Tuesday its board approved an unpaid leave of absence for President Ricardo Roa Barragan, effective May 28 for 30 days, following his scheduled vacation from April 7 to May 27.The company said Juan Carlos Hurtado Parra, executive vice president of hydrocarbons and first alternate to the president, has been appointed acting president during the period.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625392719","title":"Market Chatter: Ecopetrol Grants CEO Ricardo Roa Extended Holiday, Unpaid Leave of Absence","url":"https://stock-news.laohu8.com/highlight/detail?id=2625392719","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625392719?lang=en_us&edition=fundamental","pubTime":"2026-04-07 17:59","pubTimestamp":1775555969,"startTime":"0","endTime":"0","summary":"Ecopetrol  has granted Chief Executive Ricardo Roa an extended holiday and unpaid leave of absence, Reuters reported Tuesday, citing a company statement.The move comes amid a probe by the Colombian attorney general's office into allegations of influence peddling by Roa, the news agency reported.Roa is expected to return to his duties at the end of June, following Colombia's upcoming presidential election, according to the report.Ecopetrol didn't immediately respond to MT Newswires' request for comment.The company's shares were down 1.4% in premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625667367","title":"Ecopetrol Receives Approval for $1.25 Billion Loan to Refinance Debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2625667367","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625667367?lang=en_us&edition=fundamental","pubTime":"2026-04-06 17:48","pubTimestamp":1775468884,"startTime":"0","endTime":"0","summary":"Ecopetrol  said late Thursday that it has received approval from Colombia's Ministry of Finance and Public Credit for a $1.25 billion five-year loan as part of its comprehensive debt management strategy.The company said it will receive a loan of $350 million from Banco Bilbao Vizcaya Argentaria's  New York branch, $350 million from Bank of America , $350 million from JP Morgan Chase , and $200 million from Bank of China's Panama branch.Ecopetrol said that the loan will be repayable in four equal installments and bear a floating interest rate indexed to the secured overnight financing rate, under previously agreed terms.Proceeds will be used to repay a previous $1.2 billion loan originally secured to acquire Interconexion Electrica and to repay the remaining $50 million of a separate $500 million loan, Ecopetrol said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0310800965.SGD","LU0320765646.SGD","IE000M9KFDE8.USD","LU0149725797.USD","LU1791807156.HKD","LU1244550494.USD","LU0980610538.SGD","LU0314106906.USD","LU2106854487.HKD","LU0310799852.SGD","LU0203345920.USD","JPMO","BK4516","LU2237443622.USD","BK4201","LU0787776722.HKD","LU1629891620.HKD","LU2505996681.GBP","EC","LU0130103400.USD","LU1917777945.USD","LU1880398471.USD","BK4533","LU0130517989.USD","LU0820561909.HKD","LU1670628061.USD","IE00BJTD4V19.USD","LU2552382132.HKD","IE0034235303.USD","LU2242649171.HKD","LU2236285917.USD","LU0868494708.USD","LU0208291251.USD","LU0215105999.USD","LU0345770993.USD","LU2417539215.USD","LU2129689514.USD","LU1883839398.USD","LU1880398554.USD","LU1069347547.HKD","LU1201861249.SGD","BBVA","LU1668664300.SGD","LU0321505868.SGD","LU0496365809.HKD","LU0130102774.USD","LU0098860793.USD","IE00BFXG1179.USD","LU0306807586.USD","BAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624650779","title":"Rhythm Pharmaceuticals Announces Changes to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2624650779","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624650779?lang=en_us&edition=fundamental","pubTime":"2026-04-03 21:00","pubTimestamp":1775221200,"startTime":"0","endTime":"0","summary":"-- Kim Popovits appointed as new Director; Ed Mathers to depart -- BOSTON, April  03, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/03/3268007/0/en/Rhythm-Pharmaceuticals-Announces-Changes-to-Board-of-Directors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","AVP","BK4201","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623309105","title":"EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis","url":"https://stock-news.laohu8.com/highlight/detail?id=2623309105","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623309105?lang=en_us&edition=fundamental","pubTime":"2026-03-31 15:01","pubTimestamp":1774940460,"startTime":"0","endTime":"0","summary":"Today, ALK announced that children aged 4 and older living with severe allergies across the EU can now access the first and only needle-free adrenaline treatment for anaphylaxis, after the European Co","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/31/3265184/0/en/EURneffy-1-mg-approved-across-the-EU-as-the-first-and-only-needle-free-adrenaline-treatment-for-young-children-15-kg-at-risk-of-anaphylaxis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","BK4156","EC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179255093","title":"China Securities: Profitability in VC and EC Segments Expected to Improve, Focus on High-Beta Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1179255093","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179255093?lang=en_us&edition=fundamental","pubTime":"2026-03-30 08:18","pubTimestamp":1774829925,"startTime":"0","endTime":"0","summary":"Prices for solvents and additives declined in January and February. Recent geopolitical tensions in the Middle East have driven up energy costs, subsequently increasing the prices of solvents...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","VC","BK4201","BK4124","LU0757428866.USD","601066","EC","IE00BZ199S13.USD","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623233113","title":"588-unit Pinery Residences sells 92.5% of units at over $2,500 psf average on launch day","url":"https://stock-news.laohu8.com/highlight/detail?id=2623233113","media":"Gerine Tang Yi Qian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623233113?lang=en_us&edition=fundamental","pubTime":"2026-03-28 13:41","pubTimestamp":1774676468,"startTime":"0","endTime":"0","summary":"All two-bedroom and four-bedroom units were sold out at launch, while only one three-bedroom unit remained unsold. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/cityandcountry/new-launches/588-unit-pinery-residences-sells-925-units-over-2500-psf-average-launch?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/cityandcountry/new-launches/588-unit-pinery-residences-sells-925-units-over-2500-psf-average-launch?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622868600","title":"Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment","url":"https://stock-news.laohu8.com/highlight/detail?id=2622868600","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622868600?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:01","pubTimestamp":1774530060,"startTime":"0","endTime":"0","summary":"-- European Commission decision anticipated in second quarter of 2026 -- BOSTON, March  26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/26/3263104/0/en/Rhythm-Pharmaceuticals-Receives-Positive-CHMP-Opinion-for-IMCIVREE-setmelanotide-for-the-Treatment-of-Obesity-and-Control-of-Hunger-in-Patients-with-Acquired-Hypothalamic-Obesity-d.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC","CHMP","BK4087","BK4081","AVP","EMA","VUS","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622613478","title":"Shrinking EUA supply puts EU ETS under policy strain","url":"https://stock-news.laohu8.com/highlight/detail?id=2622613478","media":"Fastmarkets","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622613478?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:00","pubTimestamp":1774497600,"startTime":"0","endTime":"0","summary":"Shrinking EUA supply and falling prices are putting the EU ETS under strain. Fastmarkets Carbon explores how policy design led to this and what reforms the EC could implement to balance supply stress with decarbonization goals.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fastmarkets_highlight","url":"https://www.fastmarkets.com/insights/shrinking-eua-supply-eu-ets-policy-strain/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fastmarkets.com/insights/shrinking-eua-supply-eu-ets-policy-strain/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fastmarkets_highlight","symbols":["BK4156","BK4201","BK4232","ETS","EC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622008491","title":"Ecopetrol Says No Violations, Contract Breaches to Date Related to Formal Charges Against President Ricardo Roa","url":"https://stock-news.laohu8.com/highlight/detail?id=2622008491","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622008491?lang=en_us&edition=fundamental","pubTime":"2026-03-26 00:09","pubTimestamp":1774454993,"startTime":"0","endTime":"0","summary":"Ecopetrol's  board said Wednesday that there have been no violations of company regulations, nor breaches of any contracts or credit agreements to date, with regards to the allegations against company president Ricardo Roa of influence peddling by a public servant.The board's statement was made in response to inquiries from minority stakeholders regarding the situation, Ecopetrol said.In response to a letter from labor union USO asking Roa to be removed from his role and threatening a nationwide strike if it was not done, the board said it \"reaffirms its commitment to constructive dialogue with stakeholders, to maintain operational continuity, and to create value for all its shareholders.\"Earlier in March, Ecopetrol reported that the Colombian Attorney General's Office brought formal charges against Ricardo Roa for the alleged crime.Price: 14.52, Change: -0.05, Percent Change: -0.34","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622707430","title":"Ecopetrol says ‘committed’ to safeguarding interests of company, shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2622707430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622707430?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:35","pubTimestamp":1774452925,"startTime":"0","endTime":"0","summary":"Ecopetrol (EC) announced that its Board of Directors concluded a meeting on March 24, 2026, during which, among other matters, the following issues...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ecopetrol-says-committed-to-safeguarding-interests-of-company-shareholders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ecopetrol-says-committed-to-safeguarding-interests-of-company-shareholders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621585095","title":"EC urged to stop Fifa’s ‘aggressive and exploitative’ World Cup ticket prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2621585095","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621585095?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:13","pubTimestamp":1774361633,"startTime":"0","endTime":"0","summary":"World Cup tickets are set to go back on sale next month The European Commission has been urged to intervene over Fifa’s “aggressive and exploitative” ticket sale policies for this summer’s World Cup.Prices at the tournament provoked widespread outcry when they were revealed last year, with the cheapest tickets for the final initially costing 3,000 and now listed for much more.Consumer rights group Euroconsumers and fan body Football Supporters Europe have lodged a formal complaint to the EC which alleges that Fifa has “abused its monopoly position to impose excessive ticket prices and opaque and unfair purchasing conditions and processes on European fans” who wish to attend the tournament.They are calling for the EC to order Fifa to cap ticket prices in next month’s sales window, stop using dynamic pricing for European consumers, reveal exactly which seats are still unsold, and respect consumers’ rights in primary and secondary ticketing markets.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/03/GettyImages-2226685810-e1774361533785.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/03/GettyImages-2226685810-e1774361533785.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/ec-urged-to-stop-fifas-aggressive-and-exploitative-world-cup-ticket-prices/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/ec-urged-to-stop-fifas-aggressive-and-exploitative-world-cup-ticket-prices/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621722417","title":"Ecopetrol price target raised to $13 from $8.70 at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2621722417","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621722417?lang=en_us&edition=fundamental","pubTime":"2026-03-23 18:34","pubTimestamp":1774262048,"startTime":"0","endTime":"0","summary":"Goldman Sachs raised the firm’s price target on Ecopetrol (EC) to $13 from $8.70 and keeps a Neutral rating on the shares. Published first on TheFl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ecopetrol-price-target-raised-to-13-from-8-70-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ecopetrol-price-target-raised-to-13-from-8-70-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","LU1668664300.SGD","LU2237443549.SGD","LU2265009873.SGD","LU2471134952.CNY","BK4588","LU2237443465.HKD","LU1791807156.HKD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU1894683264.USD","BK4585","LU2237438978.USD","GSX","LU0061475181.USD","BK4550","LU2237443622.USD","LU1804176565.USD","LU2750360997.AUD","LU2750360641.GBP","LU2237443978.SGD","IE0034235188.USD","LU1868836757.USD","LU0345770993.USD","LU1868836914.USD","BK4127","IE0004091025.USD","IE0002270589.USD","BK4516","LU0096364046.USD","LU0742534661.SGD","LU2237443382.USD","LU0251142724.SGD","BK4533","EC","LU0106831901.USD","LU1868837300.USD","IE00BFXG1179.USD","LU2237443895.HKD","LU2471134796.USD","LU1868837136.USD","IE0004086264.USD","LU2471134879.HKD","IE00B19Z3B42.SGD","LU0251131958.USD","LU0345770308.USD","LU1894683348.USD","LU0048573561.USD","BK4552","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620739551","title":"Press Release: Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2620739551","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620739551?lang=en_us&edition=fundamental","pubTime":"2026-03-20 21:03","pubTimestamp":1774011780,"startTime":"0","endTime":"0","summary":"SHANGHAI, March 20, 2026 /PRNewswire/ -- Henlius  today announced its annual results for the year ended December 31, 2025. During the reporting period, the Company recorded revenue of RMB 6.6666 billion, representing a year-on-year increase of 16.5%, and net profit of RMB 0.8270 billion. Total R&D investment reached RMB 2.4919 billion, an increase of 35.4%. Amid continued investment in innovation, pre-R&D profit grew to RMB 2.3425 billion, up 26.2% year-on-year. This marks the third consecutive year of profitability and sustained growth of revenue since the Company first achieved full-year profitability in 2023, demonstrating resilient and sustainable profitability, alongside high-quality growth.The Company's flagship product, serplulimab , continued to deliver global commercial momentum. During the reporting period, it recorded global sales revenue of RMB 1.4926 billion, representing a year-on-year increase of 13.7%. It received approvals in 2025 in Europe and multiple emerging market","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","02696","HK0000165453.HKD","BK1161","BK4113","BK4022","TM","BK4588","MSS","EMA","BK4099","03160","HK0000320264.USD","BK4232","IND","BK4081","HK0000320223.HKD","BK4201","EC","BK4585","R","HK0000306685.HKD","HK0000306701.USD","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620627296","title":"Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2620627296","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620627296?lang=en_us&edition=fundamental","pubTime":"2026-03-20 06:30","pubTimestamp":1773959400,"startTime":"0","endTime":"0","summary":"David Meeker Quote   David Meeker Quote   Dr. Shoemaker quote   Dr. Shoemaker quote   IMCIVREE packaging   IMCIVREE packaging with vial   IMCIVREE 3D Render   IMCIVREE 3D Render  -- First and only FDA","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3259502/0/en/Rhythm-Pharmaceuticals-Announces-FDA-Approval-of-IMCIVREE-setmelanotide-for-Patients-with-Acquired-Hypothalamic-Obesity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUS","EC","LABU","BK4201","BK4588","BK4585","BMI","AVP","BK4157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620224400","title":"Press Release: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2620224400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620224400?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:21","pubTimestamp":1773919260,"startTime":"0","endTime":"0","summary":"Maturing data from the ongoing registrational intent Phase 2b ACR-368 study showed a confirmed overall response rate  of 52% in serous endometrial cancer . Late-breaking oral presentation and corporate KOL panel at ESGO 2026 highlighted strong ACR-368 data in serous EC, a high unmet need subtype responsible for 50% of EC mortality. Initiated Arm 3  and adding Arm 4  Phase 2b cohorts in all-comer  serous EC subjects. Initial Phase 1 ACR-2316 data in AP3-prioritized solid tumor types showed favorable tolerability and promising clinical activity, notably in heavily pre-treated lung cancer subjects. Cash, cash equivalents and marketable securities of $118.6 million as of December 31, 2025, expected to fund operations into the second quarter of 2027. WATERTOWN, Mass., March 19, 2026  -- Acrivon Therapeutics, Inc.  , a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3  platform deployed for rational ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CLIA","BK4201","EC","ACRV","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620274381","title":"S’pore private residential market to remain resilient despite Mideast tensions: HSBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2620274381","media":"Jovi Ho","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620274381?lang=en_us&edition=fundamental","pubTime":"2026-03-19 09:35","pubTimestamp":1773884116,"startTime":"0","endTime":"0","summary":"During periods of global uncertainty, local buyers may even allocate more capital to Singapore property. This may have contributed to the “impressive” 90% of units sold at River Modern on March 7. \n","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/cityandcountry/property/spore-private-residential-market-remain-resilient-despite-mideast-tensions?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/cityandcountry/property/spore-private-residential-market-remain-resilient-despite-mideast-tensions?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["BK4139","BK4588","HSBH","LU0052756011.USD","LU1267930227.SGD","BK4585","GLS","BK4521","EC","LU2236285917.USD","BK4207","BK4201","HSBC","LU0310800965.SGD","LU0496365809.HKD","LU0976567544.SGD","CCR","LU0211326839.USD","LU0128525689.USD","LU0211326755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620232751","title":"Press Release: Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620232751","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620232751?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:50","pubTimestamp":1773831000,"startTime":"0","endTime":"0","summary":"Company to host conference call and webcast today at 8:00 a.m. EDT. -- The European Commission  approved the 2mg/kg every-4-weeks . dosing regimen for Elfabrio in adults living with Fabry disease. providing a meaningful reduction in treatment burden without compromising. -- The EC approval triggered the Company's entitlement to a $25.0 million. milestone payment from Chiesi, strengthening the Company's cash position. and supporting an expected cash balance of approximately $50.0 million by. -- Based on current estimates, management expects total revenues in 2026 to. range from approximately $78.0 million to $83.0 million including the. -- The Phase 2 clinical trial of PRX--115 is actively enrolling; the Company. believes PRX-115 has the potential to be a best-in-class therapy,-- Continued strategic focus on rare renal diseases to build a pipeline","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","IE00BLSP4239.USD","LU0225284248.USD","BK4599","LU0306806265.USD","SG9999001176.SGD","BK4588","BK4592","LU0868494617.USD","SG9999002224.SGD","LU0058720904.USD","BK4232","LU0225771236.USD","LU0321505868.SGD","LU1894683264.USD","BK4585","LU1894683348.USD","BK4087","LU1066053197.SGD","BK4550","IE00BBT3K403.USD","LU1066051498.USD","BK4139","IE000M9KFDE8.USD","LU0170899867.USD","PFE","SG9999002232.USD","BK4022","EC","SGXZ57979304.SGD","SG9999001176.USD","R","BK4007","PLX","IE00BLSP4452.SGD","LU0985481810.HKD","BK4581","IE0002270589.USD","SG9999011175.SGD","LU1057294990.SGD","BK4533","SG9999013999.USD","BK4534","LU1883839398.USD","LU0234572021.USD","CHMP","LU0306807586.USD","IE00B19Z3B42.SGD","LU0122379950.USD","LU0321505439.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ecopetrol.com.co","stockEarnings":[{"period":"1week","weight":-0.0666},{"period":"1month","weight":-0.0666},{"period":"3month","weight":0.1276},{"period":"6month","weight":0.4569},{"period":"1year","weight":0.4949},{"period":"ytd","weight":0.3144}],"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Ecopetrol S.A. operates as an integrated energy company. The company operates through four segments: Exploration and Production; Transport and Logistics; Refining, Petrochemical and Biofuels; and Electric Power Transmission and Toll Roads Concessions. It engages in the exploration and production of oil and gas; transportation of crude oil, motor fuels, fuel oil, and other refined products, including diesel, jet, and biofuels; processing and refining crude oil; distribution of natural gas and LPG; sale of refined and petrochemical products; supplying of electric power transmission services; design, development, construction, operation, and maintenance of road and energy infrastructure projects; and supplying of information technology and telecommunications services. As of December 31, 2022, the company had approximately 9,127 kilometers of crude oil and multi-purpose pipelines. It also produces and commercializes polypropylene resins and compounds, and masterbatches; and offers industrial service sales to customers and specialized management services. It has operations in Colombia, the United States, Asia, Central America and the Caribbean, Europe, and South America. The company was formerly known as Empresa Colombiana de Petróleos and changed its name to Ecopetrol S.A. in June 2003. Ecopetrol S.A. was incorporated in 1948 and is headquartered in Bogotá, Colombia.","yearOnYearQuotes":[{"month":1,"riseRate":0.611111,"avgChangeRate":0.047964},{"month":2,"riseRate":0.5,"avgChangeRate":0.012901},{"month":3,"riseRate":0.722222,"avgChangeRate":0.035116},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.015799},{"month":5,"riseRate":0.352941,"avgChangeRate":-0.016936},{"month":6,"riseRate":0.470588,"avgChangeRate":0.005743},{"month":7,"riseRate":0.470588,"avgChangeRate":0.007592},{"month":8,"riseRate":0.470588,"avgChangeRate":0.000807},{"month":9,"riseRate":0.470588,"avgChangeRate":-0.011239},{"month":10,"riseRate":0.611111,"avgChangeRate":-0.007073},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.030395},{"month":12,"riseRate":0.611111,"avgChangeRate":0.009975}],"exchange":"NYSE","name":"Ecopetrol SA","nameEN":"Ecopetrol SA","securityTypeName":"DR","adrRate":"1:20"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ecopetrol SA(EC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Ecopetrol SA(EC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Ecopetrol SA,EC,Ecopetrol SA股票,Ecopetrol SA股票老虎,Ecopetrol SA股票老虎国际,Ecopetrol SA行情,Ecopetrol SA股票行情,Ecopetrol SA股价,Ecopetrol SA股市,Ecopetrol SA股票价格,Ecopetrol SA股票交易,Ecopetrol SA股票购买,Ecopetrol SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ecopetrol SA(EC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Ecopetrol SA(EC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction